LONDON, Sept. 13, 2024 /PRNewswire/ — Mark Edwards, CEO of ViewMind Inc., has been named “Healthcare Technology CEO of the Year USA” in the Business Worldwide 2024 CEO Awards.
The Awards celebrate exceptional individuals who drive success within their organisations, spotlighting their personal achievements and contributions to their respective industries. Unlike many awards that focus on company performance, these awards highlight the influence of senior executives who shape and lead their companies to excellence. The aim is to celebrate their leadership and inspire others to achieve similar successes.
With 25 years of experience in entrepreneurship, Mark Edwards is a pivotal force in the neurotech sector. As Co-founder and CEO of ViewMind, he has steered the company towards innovative solutions that transform brain health assessments. Under his visionary leadership, ViewMind has developed cutting-edge technology that leverages the eye as a window into the brain, providing unprecedented insights into brain function, and built a world class team.
ViewMind’s pioneering approach uses eye movement responses to visual exercises and algorithms, to detect subtle alterations in brain function and cognition. This non-invasive, cost-effective and digital method offers significant advantages over traditional brain health assessments, which often rely on expensive and invasive procedures.
“The eye is not just a gateway to the brain; it’s a part of the brain,” Edwards explained. “By leveraging this intrinsic link combined with advanced eye-tracking and machine learning digital technologies, we show promise to be able to detect and monitor subtle fine grain changes in cognition due to the progression of a disease, disorder or to objectively monitor improvement arising from an intervention”.
The technology developed by ViewMind is based on extensive scientific research led by Dr. Gerardo Fernandez, ViewMind’s Chief Science Officer and Co-founder, and backed by over 80 peer-reviewed publications, including numerous clinical studies.
Health care professionals face challenges in detecting minor changes in cognition due to the limitations of existing diagnostic tools. ViewMind addresses these issues by providing precise, real-time data that promises to improve the ability to detect small changes in cognition and to monitor treatment effects. This innovation has the potential to significantly impact healthcare by enhancing patient outcomes and introducing the possibility for brain health to be widely used as a marker of general health.
ViewMind is also working to refine its algorithms and artificial intelligence, enhancing sensitivity and enabling predictive analytics. As this groundbreaking initiative continues to push the boundaries of brain health assessment and treatment, the company is poised for significant growth. The recognition from Business Worldwide Magazine underscores the transformative potential of ViewMind’s technology and Edwards’ exceptional leadership in revolutionising the neurohealth landscape.
For more information about ViewMind’s innovative technology and ongoing developments, visit ViewMind’s website.
Further information about the Business Worldwide CEO Awards can be found at https://www.bwmonline.com/2024-ceo-awards-winners/
About Business Worldwide Magazine
Business Worldwide Magazine is the leading source of business and dealmaker intelligence throughout the world. Our quarterly magazine and online news portal enables an established audience of corporate dealmakers to track the latest news, stories and developments affecting the international markets, corporate finance, business strategy and changes in legislation. This readership includes CEO/CFO – Banks, Corporate Lawyers and Venture Capital/Private Equity Companies to name a few.
Contact
David Jones
Awards Department
E: david@bwmonline.com
W: www.bwmonline.com
SOURCE Business Worldwide Magazine
Burlington, Ontario--(Newsfile Corp. - December 24, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or…
DUBLIN, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology…
PITTSBURGH, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused…
Strategic Expansion into Cardio AI-Driven Healthcare SolutionsCollaboration to Enhance Patient-Centered Digital Healthcare TechnologiesWelcomes Key Industry…
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…